Kimberley Ober
Utrecht, UT 3584CS, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 13, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 15, 2023
The potential of PARP as a therapeutic target across pediatric solid malignancies.
Journal: BMC cancer
Published: September 27, 2022
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 18, 2022
Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.
Journal: Frontiers in oncology
Published: April 26, 2022
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression.
Journal: Journal of personalized medicine
Published: March 31, 2021
Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Journal: Investigative ophthalmology & visual science
Published: August 28, 2014
Plasma noradrenaline and state anxiety levels predict placebo response in learned immunosuppression.
Plasma noradrenaline and state anxiety levels predict placebo response in learned immunosuppression.
Journal: Clinical pharmacology and therapeutics
Published: December 15, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026